ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Scope & Guideline

Championing evidence-based practices in Alzheimer’s research.

Introduction

Immerse yourself in the scholarly insights of ALZHEIMER DISEASE & ASSOCIATED DISORDERS with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0893-0341
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationALZ DIS ASSOC DIS / Alzheimer Dis. Assoc. Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Alzheimer Disease & Associated Disorders' focuses on advancing the understanding of Alzheimer’s disease and related disorders. It aims to publish high-quality research that covers a wide spectrum of topics related to cognitive decline, dementia, and the various factors affecting these conditions.
  1. Cognitive Function and Dementia Assessment:
    Research that explores various methodologies for assessing cognitive function, including neuropsychological tests and imaging techniques, to better understand dementia progression.
  2. Biomarkers and Pathophysiology:
    Studies focusing on identifying biomarkers for Alzheimer's disease and related disorders, as well as understanding the underlying biological mechanisms contributing to neurodegeneration.
  3. Impact of Lifestyle and Environmental Factors:
    Investigations into how lifestyle choices, such as physical activity and diet, as well as environmental factors, influence cognitive health and the risk of dementia.
  4. Caregiver Studies and Psychosocial Aspects:
    Research examining the burden and quality of life for caregivers of Alzheimer’s patients, and the psychosocial impacts of dementia on individuals and families.
  5. Clinical Interventions and Therapeutics:
    Studies investigating various therapeutic approaches, including pharmacological and non-pharmacological interventions, aimed at managing or treating Alzheimer’s disease and related disorders.
  6. Diversity and Health Disparities:
    Research that highlights the differences in Alzheimer’s disease prevalence and outcomes among diverse populations, addressing health disparities in care and access.
Recent publications in 'Alzheimer Disease & Associated Disorders' reveal several emerging themes that reflect the evolving landscape of research in the field. These trends indicate areas of growing interest and relevance.
  1. Holistic and Multidisciplinary Approaches:
    There is an increasing trend towards studies that incorporate multidisciplinary perspectives, including psychological, social, and environmental factors in understanding and managing Alzheimer’s disease.
  2. Prevention and Early Intervention Strategies:
    Research focused on identifying early signs of cognitive decline and implementing preventive strategies is gaining prominence, highlighting the importance of early detection and intervention.
  3. Technology in Dementia Care:
    The use of technology, including digital health tools and telemedicine, in dementia care and research is on the rise, reflecting a shift towards innovative solutions for patient management and research methodologies.
  4. Cultural and Ethnic Studies in Dementia:
    Emerging research is increasingly examining the cultural and ethnic dimensions of dementia care, addressing how cultural factors influence perceptions, diagnosis, and treatment of Alzheimer’s disease.
  5. Neuropsychiatric Symptoms and Behavioral Interventions:
    There is heightened interest in exploring neuropsychiatric symptoms associated with dementia and the development of behavioral interventions to manage these symptoms effectively.

Declining or Waning

While the journal continues to explore a wide range of topics, some areas have shown a decline in focus over recent years. These waning themes may reflect shifts in research priorities or emerging interests in the field.
  1. Genetic Studies in Alzheimer’s Disease:
    Although genetic research remains important, the frequency of publications focusing solely on genetic variants related to Alzheimer’s has decreased, possibly due to a saturation of findings and a shift towards integrative approaches that consider environmental and lifestyle factors.
  2. Animal Models in Alzheimer Research:
    There has been a noticeable decline in studies exclusively using animal models to investigate Alzheimer’s disease, indicating a potential shift towards human-centric research and clinical studies.
  3. Traditional Pharmacological Approaches:
    The focus on traditional pharmacological treatments for Alzheimer’s disease is waning as researchers increasingly explore alternative and complementary therapies, including lifestyle interventions and holistic approaches.

Similar Journals

Psychogeriatrics

Exploring the intersection of psychiatry and gerontology.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Turkish Journal of Neurology

Fostering knowledge exchange in the realm of neurology.
Publisher: GALENOS PUBL HOUSEISSN: 1301-062XFrequency: 4 issues/year

Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Illuminating the path to effective Alzheimer's monitoring.
Publisher: WILEYISSN: Frequency: 1 issue/year

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.

AGING NEUROPSYCHOLOGY AND COGNITION

Transforming insights into aging and cognition.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1382-5585Frequency: 6 issues/year

AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.

Alzheimers & Dementia

Shaping the future of Alzheimer's research and treatment.
Publisher: WILEYISSN: 1552-5260Frequency: 12 issues/year

Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.

Frontiers in Aging Neuroscience

Unlocking Insights into Cognitive Aging.
Publisher: FRONTIERS MEDIA SAISSN: 1663-4365Frequency: 1 issue/year

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

REJUVENATION RESEARCH

Pioneering Research for a Healthier Tomorrow
Publisher: MARY ANN LIEBERT, INCISSN: 1549-1684Frequency: 6 issues/year

Rejuvenation Research is a premier journal dedicated to the advancing field of gerontology and aging research, published by Mary Ann Liebert, Inc. Established in 2000, the journal serves as a pivotal platform for the dissemination of scholarly articles that explore the complex mechanisms of aging and innovative approaches to rejuvenation. With an impact factor reflective of its robust scholarly contributions, the journal currently holds a Q4 ranking in Aging and a Q3 ranking in Geriatrics and Gerontology, showcasing its relevance in the academic community. This periodic publication, welcoming open access submissions, invites researchers, professionals, and students alike to engage with cutting-edge findings that could shape future geriatric practices and enhance quality of life. The journal underscores the importance of interdisciplinary collaboration, encouraging explorations that intersect with biochemistry, genetics, and other vital areas of study. Through its ongoing commitment to high-quality research, Rejuvenation Research remains a critical resource for understanding the biological underpinnings of aging and the strategies to mitigate its effects.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Elevating clinical practice through cutting-edge research.
Publisher: BMJ PUBLISHING GROUPISSN: 0022-3050Frequency: 12 issues/year

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

Aging Brain

Advancing Knowledge on Aging and Cognition
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

npj Aging

Bridging research and policy for a healthier aging society.
Publisher: NATURE PUBL GROUPISSN: Frequency: 1 issue/year

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.